Hematologic Malignancies and Stem Cell Transplant Team
At Stony Brook Cancer Center, we understand that a cancer diagnosis is overwhelming and not only affects your life, but those of your loved ones.
Our experts in the Hematologic Malignancies and Stem Cell Transplant team provide multidisciplinary care for blood-related cancers, cancers of the lymphatic system and bone marrow disorders. Care begins with diagnostic testing and evaluation and proceeds to advanced, coordinated treatments.
Types of Blood-Related Cancers and Diseases
The Hematologic Malignancies and Stem Cell Transplant Team at Stony Brook Cancer Center treats patients with blood cancers and bone marrow disorders. The types of conditions we treat include the following:
Is there a clinical trial right for you?
(631) 728-7425
Understanding Blood Cancers
Michael W. Schuster, MD, Director, Bone Marrow Transplant Program at Stony Brook Cancer Center, discusses leukemia, lymphoma, myeloma and other types of blood cancer, as well as clinical trials and treatment options for our patients.
Our Hematologic Malignancies and Stem Cell Transplant Team
Medical Hematology/Oncology
Bone Marrow Transplant Program
Radiation Oncology
Registered Nurses
- Stephanie Ramirez, RN
Medical Hematology/Oncology, Nurse Coordinator - Deirdre Flynn, RN
Bone Marrow Transplant Program - Nirmala Singh, RN
Bone Marrow Transplant Program - Megan Stewart, RN
Bone Marrow Transplant Program
Consultations
To schedule a consultation appointment with the Hematologic Malignancies and Stem Cell Transplant Program office, call (631) 638-1000 or for Dr. Schuster, call (631) 444-3577. The office is open from 9am to 5pm, Monday through Friday. A message can be left after hours.
Our nurse coordinators are involved in many aspects of your care, including scheduling of appointments and hospitalizations as well as seeking insurance approval for transplant procedures.
When scheduling an initial appointment, the following information will be needed:
- Name
- Address
- Phone, including cell phone or work numbers
- Date of birth
- Diagnosis
- Insurance information
- Referring physician (or current hematologist/oncologist)
Before your first appointment, please arrange for the following to be sent to our physicians:
- Physician notes (including discharge summaries & history and physicals)
- Treatment records
- All pathology slides and reports (including cytogenetic reports)
- Radiology, MRI and CT scan reports
- Radiation therapy reports
Treatment and Care
The Hematologic Malignancy Program guides our patients through all stages of treatment. At their first appointment, he or she will meet with the physician, nurse practitioner and nurse coordinator who helps to educate and coordinate the patient's care. The team works in tandem with the Stem Cell Transplant Team to ensure a seamless transition of care from treatment to transplant. Each patient’s treatment plan, including psychosocial issues, are discussed at weekly team meetings, which provides an effortless transition between in-patient and out-patient treatment and care.
At Stony Brook Cancer Center, we are turning the tide against complex blood cancers. Our CAR T-cell therapy program enhances your own immune system, reprogramming your T cells to seek and destroy cancer.
In collaboration with iCell Gene Therapeutics, we are pioneering a first-in-human clinical trial using a novel CD4 CAR T-cell therapy for hard-to-treat leukemias and lymphomas. This innovative treatment, delivered with comprehensive, multidisciplinary care right here on Long Island, offers the potential for lasting benefits and a path to further therapies.
Stony Brook opened the Blood and Bone Marrow Transplant Unit—the only one in Suffolk County—in 2004, which allows the hospital to perform both autologous stem cell transplants (from the patient), and allogenic transplants (from a donor match). The program also offers state-of-the-art infection control.
We are a member of the National Marrow Donor Program, which offers patients the opportunity to locate suitable donors should one not be located among family members. We are also a FACT (Foundation for Accreditation of Cellular Therapy) accredited Transplant Program.
